Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

ROG
Rank in Stocks #35
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in... Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Share Price
$419.17
Market Cap
$333.66B
Change (1 day)
0.50%
Change (1 year)
21.90%
Country
CH
Trade Roche Holding AG (ROG)

Category

Number of shares outstanding for Roche Holding AG (ROG)
Number of shares outstanding as of December 2025: 796.00M
According to Roche Holding AG latest financial reports and stock price the company's current number of shares outstanding is 796.00M. At the end of December 2019 the company had 856.00M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Roche Holding AG (ROG) from 2019 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 796.00M -6.35%
2021 850.00M -0.70%
2019 856.00M 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country